复发和耐火的外围T细胞淋巴瘤;治疗,挑战和未来前景
Frederik O Meeuwes1, Yasmina I M Serroukh2, Marjolein W M van der Poel3
1Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
Leukemia & lymphoma
|August 28, 2025
概括
复发或耐药的外围T细胞淋巴瘤 (PTCL) 是一个重大挑战,治疗选择有限. 本次审查侧重于管理这些侵袭性PTCL亚型,包括ALCL,nTFHL和PTCLNOS.
科学领域:
- 血液学
- 癌症学
- 临床医学
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 是一个由15种成年瘤组成的多样群体.
- 在欧洲和北美最常见的是PTCL未指定 (PTCL NOS),结节T毛囊辅助淋巴瘤,血管免疫性淋巴瘤 (nTFHL- AI) 和形大细胞淋巴瘤 (ALCL).
- 在PTCL中,复发性或耐药性 (R/R) 疾病很常见,难以管理.
研究的目的:
- 对复发性或耐火性PTCL的当前管理策略进行审查.
- 专注于特定的流行PTCL亚型:ALCL (ALK+和ALK-),nTFHL-AI和PTCLNOS.
- 突出现有治疗R/R PTCL的挑战和有限的疗效.
主要方法:
- 对R/R PTCL管理的文献综述.
- 专注于ALCL,nTFHL和PTCLNOS的治疗选择.
- 对不同PTCL实体的结果进行分析.
主要成果:
- 对于R/R PTCL的预后通常很差,除了R/R ALK阳性ALCL.
- 目前的治疗方法包括化疗,干细胞移植和向治疗,
- 研究通常包括异构的患者群体,使得结果分析复杂化.
结论:
- 由于有效和治愈疗法有限,对R/R PTCL的治疗仍然具有挑战性.
- 需要进一步的研究来改善R/ RPTCL患者的治疗结果.
- 对于特定的PTCL亚型,如ALCL,nTFHL和PTCLNOS,需要专门的方法.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

